Initiatives in which data of multiple patient cohorts are combined (e.g. the recently developed Galactosemia Patient Registry [34]) might help to facilitate studies investigating the relation between different disease parameters (e.g. variations in the GALT gene) and the severity of cognitive impairment in a larger group of patients. Here, GALT is linked to galactosemia.